Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a smart patch help older diabetics ditch the finger pricks?

NCT ID NCT07007676

First seen Sep 30, 2025

Summary

This study is testing whether a continuous glucose monitor (CGM) can help older adults with type 2 diabetes who do not use insulin achieve better blood sugar control. Participants will either wear a CGM every two months or use standard finger-stick monitoring for six months. The main goal is to see if CGM leads to a greater drop in HbA1c levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Shenzhen Buxin Community Health Service Center

    RECRUITING

    Shenzhen, Guangdong, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Dalang Community Health Service Center

    RECRUITING

    Shenzhen, Guangdong, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Fifth Avenue Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Haifu Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Haihua Community Health Service Center

    RECRUITING

    Shenzhen, Guangdong, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Haile Community Health Service Station

    RECRUITING

    Shenzhen, Guangdong, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Haile Huafu Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Haiyu Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Jiaan Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Jiangangshan Health Service Center

    RECRUITING

    Shenzhen, Guandong, 518000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Jiari Mingju Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Pingzhou Community Health Service Center

    RECRUITING

    Shenzhen, Guangdong, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Xinan Lake Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Xingdong Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Zhongliang Chuangxin Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

continuous glucose monitoring device

What this could lead to

If successful, this could show that continuous glucose monitors help older adults with type 2 diabetes manage their blood sugar better without needing insulin.

What could go wrong

This is a small, early-stage trial with only 148 participants, and the benefit may not be large enough to change standard care. The device may also be less accurate or harder to use in older adults.

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.